Strong Performance in Q3 2025
Extendicare Inc. (TSX: EXE) recently unveiled its financial performance for the three and nine months ending September 30, 2025. The company has achieved remarkable milestones, reflecting robust growth driven by strategic acquisitions and rising demand for senior care services.
Highlights from the Third Quarter
Impressive Financial Metrics
During the third quarter, Extendicare completed the acquisition of Closing the Gap for around $75.1 million. This transaction has significantly contributed to their financial results, with Adjusted EBITDA climbing by 36.6% to reach $46.9 million. This growth was fueled by the sustained expansion of their home health care segment and enhanced operations within long-term care facilities.
Growth in Home Health Care
Average daily volumes in home health care surged by 24.6% compared to the same period in the previous year. The incorporation of Closing the Gap's services played a pivotal role, adding approximately 3,500 daily service volumes. The total number of third-party beds serviced by SGP also rose to approximately 152,100, marking a 6.0% increase from Q3 2024.
Details of the Closing the Gap Acquisition
The acquisition, completed on July 1, 2025, brought on board a proficient team of 1,200 caregivers who delivered over 1.1 million service hours in 2024. This has broadened Extendicare's home health services and positioned them well to address the growing demand in the senior care market.
Financial Structure and Funding
The acquisition was financed through available cash and a draw from Extendicare's secured credit facility, amounting to $55 million. Additional earnings anticipated from the earnout linked to the transaction could reach between $1.5 million and $2 million. Furthermore, expected annualized cost synergies of approximately $1.1 million in the first year will further enhance the company’s operational efficiency.
Quarterly Financial Overview
Revenue and Profit Levels
For Q3 2025, Extendicare reported a revenue increase of $81.2 million, totaling $440.3 million, primarily driven by the new home acquisitions and increased home health service rates. Excluding out-of-period items, revenue growth still stood at an impressive 22.1%.
Operating Income Insights
Net operating income for the quarter surged by $15.8 million to $65.9 million, showcasing significant improvements in revenue generation despite increased operational costs. Meanwhile, net earnings demonstrated notable growth, achieving $24.1 million, a 48.0% increase year-over-year.
Looking Ahead: Business Updates
Focus on Long-term Care
Extendicare’s long-term care average occupancy rates showed an upward trend, rising to 98.5%. Their strategic expansion efforts are capturing the growing needs of Canada’s aging population, while the integration of new facilities continues to enhance service quality.
Financial Stability and Strategic Vision
As of September 30, 2025, Extendicare maintained a strong liquidity position, with cash and cash equivalents reaching $165.7 million. This firm financial footing allows the company to pursue further potential business opportunities and investments in senior care infrastructure.
November Dividend Announcement
Extendicare declared a cash dividend of $0.042 per share for November 2025, payable on December 15. This declaration emphasizes Extendicare's commitment to returning value to its shareholders while navigating growth in service demand.
Conference Call Details
A conference call is set to take place on November 12, 2025, at 11:30 AM EDT to discuss the quarterly results in more detail. Interested stakeholders can join via telephone or access the webcast through Extendicare's investor page.
About Extendicare
Extendicare is a premier provider of care solutions for seniors across Canada. With a mission dedicated to delivering high-quality care, Extendicare operates numerous long-term care homes and provides millions of home health care hours annually. The company's commitment to the values of quality and compassion drives its strategy to serve the growing senior population effectively.
Frequently Asked Questions
1. What were Extendicare's total revenues for Q3 2025?
Extendicare's total revenues for Q3 2025 were $440.3 million, an increase of $81.2 million compared to the prior year.
2. How did the acquisition of Closing the Gap impact Extendicare?
The acquisition significantly contributed to Extendicare's revenue and EBITDA growth, adding approximately 3,500 daily service volumes.
3. What is Extendicare’s strategy for growth in the home health care segment?
Extendicare aims to expand its services by leveraging acquisitions, enhancing current operations, and addressing the increasing demand from an aging population.
4. When is the conference call to discuss the latest financial results?
The conference call is scheduled for November 12, 2025, at 11:30 AM EDT.
5. How much is the declared cash dividend for November 2025?
Extendicare declared a cash dividend of $0.042 per share for November 2025, payable on December 15, 2025.
